January 11, 2017 Bio/Pharma/CRO Clinical Research/Diagn.

Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of CAR gene therapy in Japan

2017 2017/01/11 Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of CAR gene therapy in Japan Kusatsu/Shiga, Japan — January 11, 2017 —Takara Bio Inc. (Takara Bio), today announced that it has submitted the Clinical Trial Notification for regenerative medicines to PMDA (Pharmaceuticals and Medical Devices Agency), Japanese regulatory... Read more

November 15, 2016 Bio/Pharma/CRO Licensing, IP, and Legal M&A, Partnerships Product Launch

UC San Francisco and GE Healthcare Launch Deep Learning Partnership to Advance Care Globally

UC San Francisco’s Center for Digital Health Innovation and GE Healthcare today announced a partnership to develop a library of deep learning algorithms – complex problem-solving formulas – that will empower clinicians to make faster and more effective decisions about the diagnosis and management of patients with some of the most common and complex medical... Read more

November 13, 2016 Bio/Pharma/CRO Life Science Tools Product Launch

QIAGEN Introduces Novel Technology for Customized RNAi Assay Products

VENLO, The Netherlands, November 13 /PRNewswire-FirstCall/ -- - Worldwide First Solution for Flexible siRNA Selection Provides New Dimension of Utility and Performance in one of Life Sciences' Most Promising Disciplines QIAGEN, (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) the world's leading provider of products for pre-analytical sample preparation and a leader in molecular diagnostics, has introduced... Read more

November 1, 2016 Bio/Pharma/CRO Cell Analysis Tools M&A, Partnerships Product Launch

GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production

Chalfont St. Giles, UK and Lyon, France – 2 November, 2016 – GE Healthcare’s Life Sciences business and Valneva SE, a fully integrated vaccine biotech company, are sharing the results of a successful collaboration to optimize virus productivity in Valneva’s EB66® cell-line, a proprietary technology for the production of a wide variety of vaccines, including... Read more

October 31, 2016 Bio/Pharma/CRO Product Launch

GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation

CHALFONT ST. GILES, UK – 1 November 2016 – GE Healthcare’s Life Sciences business, a global provider of expertise, tools and technologies to the biotech industry, announced today a USD 7 million expansion project at its single-use technology manufacturing facility in Westborough, MA, US. The expanded site will manufacture a range of single-use products, including... Read more

October 26, 2016 Bio/Pharma/CRO

Exploring digital solutions to combat heart disease

GE Healthcare and LifeWatch announce an intent to develop a strategic relationship Milwaukee – 24 October 2016 – GE Healthcare today announced that it has signed a letter of intent with LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market.... Read more

October 17, 2016 Bio/Pharma/CRO M&A, Partnerships

Tata Trusts & GE Healthcare partner to skill 10,000 youth for jobs in the healthcare sector

Mumbai, October 17, 2016: Tata Trusts and GE Healthcare today announced a partnership to train 10,000 youth in various technical areas of healthcare over a three-year period. The partnership will focus on bridging the skills gap in healthcare technical or operating staff. The announcement was made in the presence of Mr. Ratan Tata, Chairman of... Read more